🇺🇸 FDA
Patent

US 7928105

Substituted 6a,7,8,9-tetrahydropyrido[3,2-e]pyrrolo[1,2-a]pyrazin-6(5H)-ones

granted A61KA61K31/4985A61K31/506

Quick answer

US patent 7928105 (Substituted 6a,7,8,9-tetrahydropyrido[3,2-e]pyrrolo[1,2-a]pyrazin-6(5H)-ones) held by Takeda Pharmaceutical Company Limited expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/4985, A61K31/506, A61K31/53, A61K31/5383